Please provide your email address to receive an email when new articles are posted on . In patients undergoing cardiac surgery, a conservative fluid management strategy reduced the amount of bolus ...
Interim safety summary of alemtuzumab vs. chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL) This is an ASCO Meeting Abstract from the 2004 ...
Despite the almost ubiquitous need for intravenous fluids in acutely ill patients, there has been little consensus on the most appropriate rate of administration and composition of intravenous fluids, ...
Children who presented to the ED with severe asthma were eligible to enter the study. Severe asthma was classified as having all four features of respiratory distress (wheezing, sternal retraction, ...
Prospective development of a patient reported outcomes (PRO) tool in desmoid tumors: A novel clinical trial endpoint. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Administration of 5-FU bolus did not affect survival for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results